Edition:
United Kingdom

People: Aquestive Therapeutics Inc (AQST.OQ)

AQST.OQ on NASDAQ Stock Exchange Global Market

3.81USD
9:00pm BST
Change (% chg)

$-0.01 (-0.26%)
Prev Close
$3.82
Open
$3.86
Day's High
$3.90
Day's Low
$3.75
Volume
24,127
Avg. Vol
44,769
52-wk High
$19.80
52-wk Low
$3.68

Kendall, Keith 

Mr. Keith J. Kendall is President, Chief Executive Officer, Director of the Company since November 2014. After having served as our President and Chief Operating Officer since November 2011, and has served on our board of directors since November 2014. Mr. Kendall also served as our Executive Vice President and Chief Financial Officer beginning in 2006. Mr. Kendall served on the board of directors of Midatech, Pharma Plc (Nasdaq: MTP), from January 2010 to December 2014. From 1999 to 2006, Mr. Kendall served as the Vice President and Managing Director of the Americas for Hewlett Packard Financial Services. Mr. Kendall held a number of positions with AT&T Capital Corporation, including President of AT&T Credit Corporation and NCR Credit Corporation, from 1985 to 1998. Mr. Kendall holds a BS from St. John’s University and an MBA from Pace University.

Basic Compensation

Total Annual Compensation, USD 925,000
Restricted Stock Award, USD 1,178,670
Long-Term Incentive Plans, USD --
All Other, USD 24,769
Fiscal Year Total, USD 2,128,440

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --